Variants in GLP1R and GIPR genes, for example, may correlate with differential GI tolerance and probiotic responsiveness, though genetic predisposition does not determine exact medication outcomes
Here's how tesamorelin vs sermorelin and other GHRH peptides compare: GHRH Peptide Comparison Table Property Tesamorelin Sermorelin CJC-1295 (No DAC) CJC-1295 DAC FDA Status FDA Approved (Egrifta) Previously approved, now discontinued Not approved Not approved Amino Acids 44 (modified GHRH) 29 (GHRH 1-29) 29 + modifications 29 + Drug Affinity Complex Half-Life ~26-38 minutes ~10-20 minutes ~30 minutes ~6-8 days Mechanism GHRH receptor agonist GHRH receptor agonist GHRH receptor agonist GHRH receptor agonist (extended) Clinical Trial Data Extensive (Phase 3 completed) Limited (older studies) Limited (Phase 1/2) Limited Primary Research Use Lipodystrophy, NAFLD, body composition GH deficiency research GH axis research Extended GH release research Key Differentiators Tesamorelin's advantages: Only GHRH analog with current FDA approval Extensive Phase 3 clinical trial data Documented efficacy for visceral fat reduction Well-characterized safety profile from prescription use Sermorelin note: Previously FDA-approved (1997) for pediatric growth hormone deficiency but discontinued by manufacturers no longer available as a prescription product in the US
Our aim is to get Vitamin B12 levels right while avoiding side effects
Ozempic (semaglutide) is a glucagon-like peptide-1 (GLP-1) receptor agonist administered via subcutaneous injection for the management of type 2 diabetes mellitus
Krady JK, Basu A, Allen CM, Xu Y, LaNoue KF, Gardner TW, et al
Maca root extract at a concentration of 450 mg supports testosterone production, male fertility health, and increased erectile function
